Acedapsone Explained

Acedapsone (INN) is an antimicrobial drug, which also has antimalarial activity.

Acedapsone is the INN for diacetyldapsone. It was synthesized and developed in 1937 by Ernest Fourneau and his team in the pharmaceutical chemistry laboratory of Pasteur Institute,[1] and it was marketed as Rodilone by the Rhône-Poulenc company.[2]

It is a long-acting prodrug of dapsone. It is used for treating leprosy.[3]

It crystallises as pale yellow needles from diethyl ether, and as leaflets from dilute ethanol. It is slightly soluble in water.

Notes and References

  1. Fourneau E, Tréfouël J, Nitti F, Bovet D . Jacques Tréfouël . Daniel Bovet . Chimiothérapie de l'infection pneumococcique par la di-(p-acétylaminophényl)-sulfone (1399 F) . fr . Compt. Rend. Acad. Sci. . July 1937 . 205 . 299 .
  2. Fourneau JP . Ernest Fourneau, fondateur de la chimie thérapeutique française: feuillets d'album. . fr . Revue d'Histoire de la Pharmacie . 1987 . 75 . 275 . 335–55 . 10.3406/pharm.1987.2904 .
  3. Shaw IN, Christian M, Jesudasan K, Kurian N, Rao GS . Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity . Leprosy Review . 74 . 2 . 141–7 . June 2003 . 10.47276/lr.74.2.141 . 12862255 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Acedapsone".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.